Cancer treatment could target inflammation in CVD
Sunday, May 5, 2013 - 07:00
in Health & Medicine
Peptide receptor radionuclide therapy with radiolabeled somatostatin analogs, an established treatment for cancer patients, could offer a novel therapeutic approach to decrease levels of inflammation in the atherosclerotic plaques of patients with cardiovascular disease, new research suggests.